Metastatic Colorectal Cancer: Tinzaparin for Blood Clot Prevention

We are studying whether tinzaparin can help prevent blood clots in patients with metastatic colorectal cancer starting their first line of treatment. This may help reduce the risk of complications related to blood clots.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Innohep
Innohep is a blood thinner medicine used to prevent and treat dangerous blood clots in the veins.
Innohep®
Innohep is a medicine used to prevent and treat dangerous blood clots in the legs or lungs.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Enoxaparin Sodium
Enoxaparin sodium is a substance that helps prevent and treat blood clots by thinning the blood.
Tinzaparin
Tinzaparin is a substance that helps prevent and treat dangerous blood clots.
Tinzaparin Sodium
Tinzaparin sodium is a blood-thinning substance used to prevent and treat dangerous blood clots.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Tinzaparin
Tinzaparin
Tinzaparin Sodium

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Champalimaud Clinical Centre
Oncologia
Belém, Portugal
Hospital Cuf Tejo S.A.
Oncologia
Belém, Portugal
Hospital Da Luz S.A.
Oncologia
Benfica, Portugal

Sponsor: Grupo Gallego De Investigacion En Tumores Digestivos
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.